This page lists the SEC filings reported by Boxer Capital, LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-22 | Boxer Capital, LLC | Century Therapeutics, Inc. | 4,901,603 | 5.8% | EDGAR |
| SC 13G/A | 2024-02-14 | Boxer Capital, LLC | PMV Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-12 | Boxer Capital, LLC | FATE THERAPEUTICS INC | 6,171,000 | 6.3% | EDGAR |
| SC 13D/A | 2024-02-08 | Boxer Capital, LLC | Tyra Biosciences, Inc. | 6,448,359 | 12.3% | EDGAR |
| SC 13D/A | 2024-01-25 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G | 2024-01-18 | Boxer Capital, LLC | Nkarta, Inc. | 4,407,350 | 9.0% | EDGAR |
| SC 13D/A | 2023-12-18 | Boxer Capital, LLC | Rain Oncology Inc. | 2,933,152 | 9.9% | EDGAR |
| SC 13D/A | 2023-10-12 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | 3,534,249 | 4.8% | EDGAR |
| SC 13D/A | 2023-08-16 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | 3,534,249 | 4.8% | EDGAR |
| SC 13D/A | 2023-05-25 | Boxer Capital, LLC | Rain Oncology Inc. | 2,815,562 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Boxer Capital, LLC | PMV Pharmaceuticals, Inc. | 3,163,795 | 6.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Boxer Capital, LLC | IDEAYA Biosciences, Inc. | 2,202,812 | 4.6% | EDGAR |
| SC 13G/A | 2023-02-14 | Boxer Capital, LLC | Milestone Pharmaceuticals Inc. | 698,861 | 2.0% | EDGAR |
| SC 13D/A | 2022-11-08 | Boxer Capital, LLC | Rain Therapeutics Inc. | 2,510,127 | 10.0% | EDGAR |
| SC 13G | 2022-09-19 | Boxer Capital, LLC | SpringWorks Therapeutics, Inc. | 3,421,541 | 5.7% | EDGAR |
| SC 13D/A | 2022-06-16 | Boxer Capital, LLC | Tyra Biosciences, Inc. | 6,323,359 | 15.1% | EDGAR |
| SC 13D/A | 2022-05-11 | Boxer Capital, LLC | iTeos Therapeutics, Inc. | 2,154,058 | 6.1% | EDGAR |
| SC 13D/A | 2022-03-21 | Boxer Capital, LLC | iTeos Therapeutics, Inc. | 3,142,058 | 8.9% | EDGAR |
| SC 13G/A | 2022-02-14 | Boxer Capital, LLC | Merus N.V. | 1,900,000 | 4.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Boxer Capital, LLC | Biomea Fusion, Inc. | 1,188,405 | 4.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.